279 related articles for article (PubMed ID: 26370561)
1. Nanotoxicology: advances and pitfalls in research methodology.
Azhdarzadeh M; Saei AA; Sharifi S; Hajipour MJ; Alkilany AM; Sharifzadeh M; Ramazani F; Laurent S; Mashaghi A; Mahmoudi M
Nanomedicine (Lond); 2015; 10(18):2931-52. PubMed ID: 26370561
[TBL] [Abstract][Full Text] [Related]
2. Towards an alternative testing strategy for nanomaterials used in nanomedicine: lessons from NanoTEST.
Dusinska M; Boland S; Saunders M; Juillerat-Jeanneret L; Tran L; Pojana G; Marcomini A; Volkovova K; Tulinska J; Knudsen LE; Gombau L; Whelan M; Collins AR; Marano F; Housiadas C; Bilanicova D; Halamoda Kenzaoui B; Correia Carreira S; Magdolenova Z; Fjellsbø LM; Huk A; Handy R; Walker L; Barancokova M; Bartonova A; Burello E; Castell J; Cowie H; Drlickova M; Guadagnini R; Harris G; Harju M; Heimstad ES; Hurbankova M; Kazimirova A; Kovacikova Z; Kuricova M; Liskova A; Milcamps A; Neubauerova E; Palosaari T; Papazafiri P; Pilou M; Poulsen MS; Ross B; Runden-Pran E; Sebekova K; Staruchova M; Vallotto D; Worth A
Nanotoxicology; 2015 May; 9 Suppl 1():118-32. PubMed ID: 25923349
[TBL] [Abstract][Full Text] [Related]
3. Assessing nanoparticle toxicity in cell-based assays: influence of cell culture parameters and optimized models for bridging the in vitro-in vivo gap.
Joris F; Manshian BB; Peynshaert K; De Smedt SC; Braeckmans K; Soenen SJ
Chem Soc Rev; 2013 Nov; 42(21):8339-59. PubMed ID: 23877583
[TBL] [Abstract][Full Text] [Related]
4. Toxicity evaluation of engineered nanoparticles for medical applications using pulmonary epithelial cells.
Guadagnini R; Moreau K; Hussain S; Marano F; Boland S
Nanotoxicology; 2015 May; 9 Suppl 1():25-32. PubMed ID: 24286383
[TBL] [Abstract][Full Text] [Related]
5. Exploiting the novel properties of protein coronas: emerging applications in nanomedicine.
Hamad-Schifferli K
Nanomedicine (Lond); 2015 May; 10(10):1663-74. PubMed ID: 26008198
[TBL] [Abstract][Full Text] [Related]
6. Silver nanoparticle protein corona and toxicity: a mini-review.
Durán N; Silveira CP; Durán M; Martinez DS
J Nanobiotechnology; 2015 Sep; 13():55. PubMed ID: 26337542
[TBL] [Abstract][Full Text] [Related]
7. Protein-Nanoparticle Interaction-Induced Changes in Protein Structure and Aggregation.
Kim Y; Ko SM; Nam JM
Chem Asian J; 2016 Jul; 11(13):1869-77. PubMed ID: 27062521
[TBL] [Abstract][Full Text] [Related]
8. Intracellular uptake, transport, and processing of gold nanostructures.
Chithrani DB
Mol Membr Biol; 2010 Oct; 27(7):299-311. PubMed ID: 20929337
[TBL] [Abstract][Full Text] [Related]
9. A fruit fly in the nanoworld: once again Drosophila contributes to environment and human health.
Vecchio G
Nanotoxicology; 2015 Mar; 9(2):135-7. PubMed ID: 24766263
[TBL] [Abstract][Full Text] [Related]
10. Exocytosis of nanoparticles from cells: role in cellular retention and toxicity.
Sakhtianchi R; Minchin RF; Lee KB; Alkilany AM; Serpooshan V; Mahmoudi M
Adv Colloid Interface Sci; 2013 Dec; 201-202():18-29. PubMed ID: 24200091
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticles: cellular uptake and cytotoxicity.
Adjei IM; Sharma B; Labhasetwar V
Adv Exp Med Biol; 2014; 811():73-91. PubMed ID: 24683028
[TBL] [Abstract][Full Text] [Related]
12. Nanotoxicology and in vitro studies: the need of the hour.
Arora S; Rajwade JM; Paknikar KM
Toxicol Appl Pharmacol; 2012 Jan; 258(2):151-65. PubMed ID: 22178382
[TBL] [Abstract][Full Text] [Related]
13. The "sweet" side of the protein corona: effects of glycosylation on nanoparticle-cell interactions.
Wan S; Kelly PM; Mahon E; Stöckmann H; Rudd PM; Caruso F; Dawson KA; Yan Y; Monopoli MP
ACS Nano; 2015 Feb; 9(2):2157-66. PubMed ID: 25599105
[TBL] [Abstract][Full Text] [Related]
14. The nanoparticle biomolecule corona: lessons learned - challenge accepted?
Docter D; Westmeier D; Markiewicz M; Stolte S; Knauer SK; Stauber RH
Chem Soc Rev; 2015 Oct; 44(17):6094-121. PubMed ID: 26065524
[TBL] [Abstract][Full Text] [Related]
15. Organization of research team for nano-associated safety assessment in effort to study nanotoxicology of zinc oxide and silica nanoparticles.
Kim YR; Park SH; Lee JK; Jeong J; Kim JH; Meang EH; Yoon TH; Lim ST; Oh JM; An SS; Kim MK
Int J Nanomedicine; 2014; 9 Suppl 2(Suppl 2):3-10. PubMed ID: 25565821
[TBL] [Abstract][Full Text] [Related]
16. Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles.
Hadjidemetriou M; Al-Ahmady Z; Kostarelos K
Nanoscale; 2016 Apr; 8(13):6948-57. PubMed ID: 26961355
[TBL] [Abstract][Full Text] [Related]
17. In vivo degeneration and the fate of inorganic nanoparticles.
Feliu N; Docter D; Heine M; Del Pino P; Ashraf S; Kolosnjaj-Tabi J; Macchiarini P; Nielsen P; Alloyeau D; Gazeau F; Stauber RH; Parak WJ
Chem Soc Rev; 2016 May; 45(9):2440-57. PubMed ID: 26862602
[TBL] [Abstract][Full Text] [Related]
18. Quantum dot cytotoxicity and ways to reduce it.
Winnik FM; Maysinger D
Acc Chem Res; 2013 Mar; 46(3):672-80. PubMed ID: 22775328
[TBL] [Abstract][Full Text] [Related]
19. Biological impact assessment of nanomaterial used in nanomedicine. introduction to the NanoTEST project.
Juillerat-Jeanneret L; Dusinska M; Fjellsbø LM; Collins AR; Handy RD; Riediker M;
Nanotoxicology; 2015 May; 9 Suppl 1():5-12. PubMed ID: 23875681
[TBL] [Abstract][Full Text] [Related]
20. Surface engineering of inorganic nanoparticles for imaging and therapy.
Nam J; Won N; Bang J; Jin H; Park J; Jung S; Jung S; Park Y; Kim S
Adv Drug Deliv Rev; 2013 May; 65(5):622-48. PubMed ID: 22975010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
